强化是否会影响发生甲状腺功能升高时心房动的风险? 一个基于国家注册的队列队列
Line T Møllehave1, Nils Knudsen2, Eva Prescott3
1Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Clinical endocrinology
|March 4, 2024
概括
强化剂 (IF) 可能会降低甲状腺功能高的患者心房动 (AF) 的风险. 这种公共卫生措施可以减少甲状腺功能障碍的发生率和相关的AF负担.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 公共卫生 营养 公共卫生 营养
背景情况:
- 强化 (IF) 影响甲状腺功能障碍的发生率和患者人口统计.
- 甲状腺功能升高患者个人资料的变化可能会影响心房动 (AF) 风险.
- 在甲状腺功能增高患者中,IF对AF风险的影响需要进行研究.
研究的目的:
- 评估强化 (IF) 如何影响发生的甲状腺功能升和心房动 (AF) 之间的关联.
- 为了检查增加人口摄入量对甲状腺功能障碍患者的AF风险的影响.
主要方法:
- 对1997-2018年丹麦全国性登记册的分析.
- 包括62,201名发生过高甲状腺患者的AF诊断.
- 调整为人口因素和并发症的普森回归模型被用于分析每年IF引入后AF的相对风险 (RR).
主要成果:
- 在IF后观察到AF风险的初始,非显著增加,随后到2017年降至RR0.76 (0.62-0.94).
- 在AF风险发展中没有发现性别,年龄组或地理区域的显著差异.
- 总体而言,7.9%的甲状腺功能增高患者被诊断为AF.
结论:
- 强化剂 (IF) 可能会降低甲状腺功能障碍症患者同时发生的AF的风险.
- IF不仅可以降低甲状腺功能障碍的发生率,还可以降低剩余甲状腺功能障碍患者的患病负担.
- 需要进一步证实这些发现是合理的.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
994
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
994
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Functions of Thyroid Hormones
2.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
743
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
743


